Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Bio N Tech
Bio N Tech
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Eurofarma to manufacture Pfizer-BioNTech doses for Latin America
Annual production is planned to exceed 100 million COVID-19 vaccine doses annually and all of these will exclusively be distributed within Latin America
Manufacturing
Biovac to manufacture Pfizer-BioNTech vaccine for African Union
Pfizer and BioNTech expect the Cape Town facility to be incorporated into the vaccine supply chain by the end of 2021
Manufacturing
Takara Bio signs license and supply agreement with BioNTech
Under the agreement BioNTech is allowed to use RetroNectin for production of its cell & gene therapy products
Manufacturing
Evonik delivers first lipids from German facility to BioNTech
The lipids are used for Pfizer and BioNTech's COVID-19 vaccine, as part of a lipid nanoparticle
Finance
Report details relative uptake of COVID-19 vaccines in EU
$746 m worth of the vaccines have been distributed in the EU with Pfizer taking 67% market share
Packaging
Softbox supports Pfizer in COVID-19 vaccine distribution
When correctly managed, the company says, the ULT Shipper can be used to store vaccines for in excess of 30 days
Manufacturing
AMRI provides excipient manufacturing services for Pfizer-BioNTech
The company has been chosen as part of a network of manufacturers to support the vaccine's continued supply
Subscribe now